TABLE 1 Comparison of WHO/ISUP Grade and Stage with Clinical Data in 120 Papillary Urothelial pTa and pT1 Urothelial Neoplasms
WHO/ISUP grade | Pap | LMP | LG | HG | Total | P-value |
|---|---|---|---|---|---|---|
Stage | ||||||
pTa | 100% (8) | 100% (8) | 97.6% (41) | 50% (31) | 73.3% (88) | <0.005 |
pT1 | 0 | 0 | 2.4% (1) | 50% (31) | 26.7% (32) | |
Total % (no. of cases) | 6.7% (8) | 6.7% (8) | 35% (42) | 51.7% (62) | 100% (120) | |
Mean age (yrs)* | 42.8 | 53.4 | 64.5 | 65.6 | 62.9 | <0.005 |
Sex (M:F) ratio | 3:1 | 1:1.7 | 7.4:1 | 7.9:1 | 5.3:1 | |
Recurrence** | 0 | 33.3% | 64.1% | 56.4% | 54.7% | 0.02 |
Progression in stage*** | 0 | 0 | 10.5% | 27.1% | 17.3% | 0.031 |
pTa to pT1 | 0 | 0 | 2.6% | 8.3% | 8.6% | |
Muscle invasion | 0 | 0 | 5.3% | 6.3% | 5.1% | |
Metastasis | 0 | 0 | 5.3% | 8.3% | 6.1% | |
Death from disease | 0 | 0 | 5.3% | 16.7% | 10.2% | |
